The use of cefiderocol for extensively drug-resistant gram-negative bacterial infections: a case series

被引：0
|
作者：
Sadyrbaeva-Dolgova, S. [1 ]
Martin-Roldan, A. [1 ]
Espinosa-Rodriguez, A. [1 ]
Jimenez-Morles, A. [1 ]
Hidalgo-Tenorio, C. [1 ]
机构：
[1] Hosp Univ Virgen de las Nieves, Granada, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2022年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PP177
引用
收藏
页码：1553 / 1554
页数：2
相关论文
共 50 条
  • [21] Comparative pharmacokinetics of polymyxin B in critically ill elderly patients with extensively drug-resistant gram-negative bacteria infections
    Zeng, Juan
    Leng, Bing
    Guan, Xiaoyan
    Jiang, Shuangyan
    Xie, Maoyu
    Zhu, Wenying
    Tang, Yue
    Zhang, Lin
    Sha, Jing
    Wang, Tengfei
    Ding, Min
    Guo, Nan
    Jiang, Jinjiao
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] Drug-resistant gram-negative uropathogens: A review
    Khoshnood, Saeed
    Heidary, Mohsen
    Mirnejad, Reza
    Bahramian, Aghil
    Sedighi, Mansour
    Mirzaei, Habibollah
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2017, 94 : 982 - 994
  • [23] Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
    Karaiskos, Ilias
    Giamarellou, Helen
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (10) : 1351 - 1370
  • [24] Extensively drug-resistant and multidrug-resistant gram-negative pathogens in the neurocritical intensive care unit
    Munari, Marina
    Franzoi, Francesca
    Sergi, Massimo
    De Cassai, Alessandro
    Geraldini, Federico
    Grandis, Marzia
    Caravello, Massimiliano
    Boscolo, Annalisa
    Navalesi, Paolo
    [J]. ACTA NEUROCHIRURGICA, 2022, 164 (03) : 859 - 865
  • [25] Extensively drug-resistant and multidrug-resistant gram-negative pathogens in the neurocritical intensive care unit
    Marina Munari
    Francesca Franzoi
    Massimo Sergi
    Alessandro De Cassai
    Federico Geraldini
    Marzia Grandis
    Massimiliano Caravello
    Annalisa Boscolo
    Paolo Navalesi
    [J]. Acta Neurochirurgica, 2022, 164 : 859 - 865
  • [26] Pharmacokinetic evaluation of cefiderocol for the treatment of multidrug resistant Gram-negative infections
    Drwiega, Emily N.
    Griffith, Nicole C.
    Danziger, Larry H.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (04) : 245 - 259
  • [27] Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens
    Pollini, Simona
    Brunetti, Jlenia
    Sennati, Samanta
    Rossolini, Gian Maria
    Bracci, Luisa
    Pini, Alessandro
    Falciani, Chiara
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2017, 23 (04) : 329 - 333
  • [28] Predictors of mortality in patients with extensively drug-resistant gram-negative pneumonia receiving colistin therapy
    Wi, Y. M.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 : S110 - S111
  • [29] Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment
    Raphael, Eva
    Riley, Lee W.
    [J]. FRONTIERS IN MEDICINE, 2017, 4
  • [30] Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms
    Kadri, Sameer S.
    Strich, Jeffrey R.
    Swihart, Bruce J.
    Hohmann, Samuel
    Dekker, John P.
    Palmore, Tara
    Bonne, Stephanie
    Freeman, Bradley
    Raybould, Jillian
    Shah, Nirav G.
    Patel, Devang
    Husson, Jennifer
    Jacobs, Mitchell D.
    Duong, Lan
    Follmann, Dean
    Hooper, David C.
    Timpone, Joseph
    Danner, Robert L.
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2019, 47 (09) : 1040 - 1047
12345